A Self-Fulfilling Prophecy: Comparing 177Lu-PSMA Radioligand Therapy in Taxane-Naïve Versus Posttaxane Metastasized Prostate Cancer Patients?
- PMID: 30926648
- DOI: 10.2967/jnumed.119.228742
A Self-Fulfilling Prophecy: Comparing 177Lu-PSMA Radioligand Therapy in Taxane-Naïve Versus Posttaxane Metastasized Prostate Cancer Patients?
Comment on
-
Clinical Outcomes of 177Lu-PSMA Radioligand Therapy in Earlier and Later Phases of Metastatic Castration-Resistant Prostate Cancer Grouped by Previous Taxane Chemotherapy.J Nucl Med. 2019 Jul;60(7):955-962. doi: 10.2967/jnumed.118.216820. Epub 2019 Jan 25. J Nucl Med. 2019. PMID: 30683770
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous